Recall Register

Drug recall: Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC…

Class II FDA enforcement event 95900. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

RemedyRepack Inc. started this drug recall on 2 Dec 2024. The firm address in the FDA record is in Indiana, PA. FDA put the recall in Class II. FDA event 95900 has 1 product record. The first FDA enforcement report date is 1 Jan 2025. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide in the US

Recalling firm

RemedyRepack Inc., Indiana, PA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 95900: product records
Recall numberProductQuantityClassStatusReport date
D-0165-2025Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PAa) 1,564 cards, b) 799 bottlesClass IIOngoing1 Jan 2025

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2024
319
Share of these events in Class II
71%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
36

Other events of the firm

Other FDA enforcement events of RemedyRepack Inc.
InitiatedProduct (first record)TypeClassRecords
22 Apr 2025Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 157DrugClass II1
24 Mar 2025Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 157DrugClass II1
24 Jan 2025Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ DrugClass II1
26 Jun 2024Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG: Glenmark, MahwDrugClass II1
31 May 2024Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518DrugClass II1
2 May 2024TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blister pack, NDC 7051DrugClass II1
1 May 2023LORazepam Injection, 2mg / mL Single Dose vial 1ml vial, Rx Only, MFG Akorn Lake Forest IL 60045, Repackaged by: RemedyRDrugClass II3
20 Mar 2023Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2921DrugClass II14
20 Dec 2022Rifampin Capsules, 300 mg, 30 count blister card, Rx only, Mfg: Lupin Pharma, Baltimore, MD 21202, original NDC 68180-06DrugClass II1
5 Dec 2022Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., DrugClass II1

RemedyRepack Inc.: all 36 events

Official channels

Cite this page

Recall Register. FDA enforcement event 95900. https://recallregister.com/fda/ii/95900/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide in the US
What quantity of product is in FDA event 95900?
The FDA record gives this quantity: a) 1,564 cards, b) 799 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2024 have the same class?
71% of the 319 drug events that started in 2024 are in Class II.